Admission electronic fetal monitoring does not improve neonatal outcomes

Admission electronic fetal monitoring did not decrease neonatal morbidity and mortality compared with intermittent auscultation.

Patients in the admission fetal monitoring group were more likely to receive continuous electronic monitoring and fetal blood sampling, but there were no significant differences in the rates of operative deliveries or episiotomy. Institutions not routinely using admission electronic fetal monitoring should not start; those that do may not be benefiting their patients.

Admission electronic fetal monitoring did not decrease neonatal morbidity and mortality compared with intermittent auscultation.

Patients in the admission fetal monitoring group were more likely to receive continuous electronic monitoring and fetal blood sampling, but there were no significant differences in the rates of operative deliveries or episiotomy. Institutions not routinely using admission electronic fetal monitoring should not start; those that do may not be benefiting their patients.

Admission electronic fetal monitoring did not decrease neonatal morbidity and mortality compared with intermittent auscultation.

Patients in the admission fetal monitoring group were more likely to receive continuous electronic monitoring and fetal blood sampling, but there were no significant differences in the rates of operative deliveries or episiotomy. Institutions not routinely using admission electronic fetal monitoring should not start; those that do may not be benefiting their patients.